Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My Cart

Main menu

  • Home
  • Articles
    • Archive
  • About the Journal
    • About EC
    • For Librarians
    • For Advertisers
    • FAQ
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Eukaryotic Cell
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Archive
  • About the Journal
    • About EC
    • For Librarians
    • For Advertisers
    • FAQ
Articles

Loss of Regulators of Vacuolar ATPase Function and Ceramide Synthesis Results in Multidrug Sensitivity in Schizosaccharomyces pombe

Keren Dawson, W. Mark Toone, Nic Jones, Caroline R. M. Wilkinson
Keren Dawson
Paterson Institute for Cancer Research, University of Manchester, Wilmslow Road, Manchester M20 4BX, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
W. Mark Toone
Paterson Institute for Cancer Research, University of Manchester, Wilmslow Road, Manchester M20 4BX, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nic Jones
Paterson Institute for Cancer Research, University of Manchester, Wilmslow Road, Manchester M20 4BX, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: njones@picr.man.ac.uk cwilkinson@picr.man.ac.uk
Caroline R. M. Wilkinson
Paterson Institute for Cancer Research, University of Manchester, Wilmslow Road, Manchester M20 4BX, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: njones@picr.man.ac.uk cwilkinson@picr.man.ac.uk
DOI: 10.1128/EC.00037-08
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIG. 1.
    • Open in new tab
    • Download powerpoint
    FIG. 1.

    Characterization of the multidrug-sensitive phenotype of a rav1-1 mutant. (A) Increasing dilutions of wild-type (wt) and rav1-1 mutant cells were plated on YE (control) plates with and without doxorubicin at 20 μg/ml, camptothecin at 50 μg/ml, bleomycin at 0.25 μg/ml, cycloheximide at 7.5 μg/ml, hydroxyurea at 10 mM, and fluconazole at 20 μg/ml. The plates were photographed after incubation at 30°C for 3 days. (B) Isolation of the rav1 gene and the lag1 multicopy suppressor of rav1-1. rav1-1 mutant cells were transformed with the pREP1 vector (vector) or the rav1 or lag1 clone isolated from the S. pombe genomic library. Cells were plated on either minimal medium (control) or minimal medium containing CaCl2. (C) Overexpression of lag1 can partially rescue the drug and calcium sensitivity caused by a rav1Δ allele. rav1-1 or rav1Δ mutant cells were transformed with the pREP1 vector (vector), the lag1 genomic clone (genomic), or the lag1 cDNA expressed from the nmt1 promoter (cDNA). Cells were plated on either minimal medium (control) or minimal medium containing doxorubicin (20 μg/ml), bleomycin (0.5 μg/ml), or CaCl2 (100 mM). (D) Western blot assay of wild-type and mutant Rav1 proteins tagged with 13 copies of the myc epitope. The upper and lower arrows indicate the full-length and truncated Rav1 proteins, respectively. wt indicates an untagged strain. Loading was assessed with antitubulin antibodies.

  • FIG. 2.
    • Open in new tab
    • Download powerpoint
    FIG. 2.

    Multidrug- and heavy-metal-sensitive phenotypes of lac1Δ and rav1Δ mutants. (A) A lac1Δ but not a lag1Δ mutant is sensitive to a range of drugs. The strains were plated on YE containing bleomycin (0.5 μg/ml), cycloheximide (CHX; 7.5 μg/ml), fluconazole (20 μg/ml), and camptothecin (50 μg/ml). After a week, on the control plate, the lac1Δ mutant had grown to the same extent as the wild type (wt) had after 3 days. (B) Wild-type and rav1Δ, lac1Δ, and lag1Δ mutant cells were plated onto YE (control) plates and YE containing 200 mM CaCl2. (C) Wild-type and rav1Δ and lac1Δ mutant cells were plated onto YE (control) and YE containing either 1 mM ZnSO4 or 0.2 mM CdSO4. (D) rav1Δ mutant cells were transformed with the empty vector, the rav1 or lag1 (grav1 or glag1) genomic clone, or a pREP1 vector containing the cDNA of rav1 or lag1 (clag1 or clac1). The cells were plated on minimal medium alone or on minimal medium containing 200 mM CaCl2, doxorubicin (50 μg/ml), or fluconazole (20 μg/ml). (E) lac1Δ cells were transformed with the empty vector, pREP1, the pREP41 vector containing the cDNA of lag1, or pREP1lac1. The cells were plated on minimal medium alone or medium containing 100 mM CaCl2. (F) Wild-type cells were transformed with the empty pREP1 vector, pREP1lag1, or pREP1lac1 and plated on minimal medium alone or on medium containing doxorubicin (50 μg/ml), fluconazole (20 μg/ml), bleomycin (0.5 μg/ml), or cycloheximide (15 μg/ml). Plates were incubated for 2 days at 30°C.

  • FIG. 3.
    • Open in new tab
    • Download powerpoint
    FIG. 3.

    Mutations in rav1 and lac1 lead to increased accumulation of doxorubicin. (A) The strains were plated on YE with 50 μg/ml doxorubicin. (B) Log phase cells were grown in YE containing 50 μg/ml doxorubicin before imaging. The size bar represents 15 μm. Images taken with longer exposure times are shown for wild-type (wt) and lag1Δ mutant cells so that the outline of cells that have not taken up the drug can be seen. (C) The numbers of cells displaying a fluorescent signal in panel A were quantified and expressed as a percentage of the total number of cells counted. At least 200 cells were observed for each strain, and the average of the data from three independent experiments is shown with standard deviations. (D) Higher magnification of a lac1Δ mutant cell exposed to doxorubicin as in panel B. For this image, the cells had been exposed to doxorubicin and then resuspended in water to promote vacuolar fusion. This enabled clearer observation of the vacuoles so that the cytoplasmic accumulation of doxorubicin and exclusion of the drug from the vacuoles could be visualized.

  • FIG. 4.
    • Open in new tab
    • Download powerpoint
    FIG. 4.

    S. pombe Rav1 is part of a RAVE-like complex. (A) SpRav1 binds to Skp1. The Rav1-13myc protein was immunoprecipitated (IP) from whole-cell extracts (WCE) with anti-myc antibodies. A nontagged strain (wt) was used as a control. The experiment was also carried out with a strain where the skp1 gene is fused to the hemagglutinin epitope under the control of the nmt1 promoter. This was performed in the presence or absence of thiamine (Thi) to vary the amount of Skp1 expressed. Extracts were analyzed with anti-Skp1 antibodies. The immunoprecipitated Rav1 protein was detected with anti-myc antibodies. (B) Protein sequence alignment of S. cerevisiae Rav2 with its putative homologues from C. glabrata, C. albicans, and S. pombe. The accession numbers of the latter three sequences, respectively, are as follows: GenBank, CAG59121.1; Candida DB, CA1654; GenBank, CAA20308.1. Alignment was performed with ClustalX. Residues identical in all four species are shaded in black; those conserved across two or three species are shaded in dark gray; conservative changes are shaded in light gray. The amino acid positions are indicated on the right. (C) SpRav2 (SPBC3H7.12) interacts with Skp1. The Rav2-13myc protein was immunoprecipitated from whole-cell extracts. A nontagged strain (wt) was used as a negative control, and rav1-13myc was used as a positive control. Skp1 was detected as in panel A. The immunoprecipitated Rav2 protein was detected with anti-myc antibodies. (D) The S. pombe rav2Δ mutant is partially sensitive to drugs and calcium. The concentrations used were 50 μg/ml doxorubicin and 100 mM CaCl2.

  • FIG. 5.
    • Open in new tab
    • Download powerpoint
    FIG. 5.

    Rav1 interacts with the V-ATPase and influences its function. (A) Rav1-13myc protein was purified, and coprecipitating proteins were identified by gel electrophoresis and silver staining in comparison to the immunoprecipitate from a nontagged control (wt). The arrow corresponds to the prominent band observed upon silver staining, which was identified as Vma2. (B) Loss of Rav1 results in vacuolar acidification defects. Wild-type and rav1Δ mutant cells were exposed to quinacrine and imaged by fluorescence microscopy. Equal exposure times are shown for both strains. The size bar represents 10 μm. (C) Epistasis analysis of the rav1Δ and vma1Δ mutants. Wild-type and vma1Δ, rav1Δ, and vma1Δrav1Δ mutant cells were plated on 20 μg/ml fluconazole, 100 mM CaCl2, and 50 μg/ml doxorubicin. (D) Rav1 protein is localized throughout the cytoplasm. Indirect immunofluorescence analysis was carried out with either wild-type untagged or rav1-13myc mutant cells with anti-myc. The scale bar represents 10 μm. DAPI, 4′,6′-diamidino-2-phenylindole.

  • FIG. 6.
    • Open in new tab
    • Download powerpoint
    FIG. 6.

    Characterization of the lac1Δ mutant. (A) lac1Δ mutant cells display a slow-growth phenotype. Wild-type (wt) and rav1Δ, lac1Δ, and lag1Δ mutant cells were diluted in YE to 2 × 106/ml, and their growth was assayed by measuring absorbance at 600 nm. Symbols: filled circles, wild type; empty circles, lag1Δ mutant; filled squares, lac1Δ mutant; filled squares, rav1Δ mutant. (B) The lac1Δ mutant is sensitive to heat shock. Cells were shifted to 50°C for 15 min, plated on YE, and then incubated at 30°C. Control samples were grown at 30°C before plating. All strains were grown on the same plates; a mutant not relevant to this study has been removed (between the lag1Δ and lac1Δ mutants). After a week, on the control plate, lac1Δ mutant cells had grown to the same extent as the wild type had after 3 days, but not those exposed to heat shock. (C) lac1Δ mutant cells display an abnormal distribution of sterols in their plasma membrane. Wild-type and lac1Δ, lag1Δ, and rav1Δ mutant cells were treated with filipin and examined by fluorescence microscopy. (D) The rav1Δ mutant was transformed with the lag1 genomic clone (lag1), the rav1 genomic clone (rav1), or the empty vector. Transformants were exposed to quinacrine and imaged by fluorescence microscopy. Equal exposure times are shown for all strains. The size bar represents 10 μm. (E) The vma3Δ mutant was transformed with the empty vector, the pREP1 vector containing the lag1 (lag1) or vma3 (vma3) cDNA, and the pREP41 vector containing the lag1 cDNA (41lag1). Cells were plated on minimal medium and minimal medium containing 100 mM CaCl2 (100 mM) or fluconazole (50 μg/ml). (F) The vma3Δ mutant was transformed with the pREP1 vector (Vector), the pREP1lag1 cDNA (lag1), or the pREP1vma3 cDNA (vma3). Transformants were exposed to quinacrine and imaged by fluorescence microscopy. Equal exposure times are shown for all strains. The size bar represents 10 μm.

Tables

  • Figures
  • TABLE 1.

    Yeast strains used in this study

    StrainGenotypeaSource or reference
    NJ1 (wild type)h+ his7-366 ade6-M210Laboratory stock
    NJ3h+ rav1::kanr his7-366 ade6-M210This study
    NJ4h+ lag1::kanr his7-366 ade6-M210This study
    NJ5h− lac1::kanr his7-366 ade6-M210This study
    NJ13h+ rav1-13myc:kanrhis7-366 ade6-M210This study
    NJ88h? rav1::kanrlag1::kanr his7-366 ade6This study
    NJ89h? rav1::kanrlac1::kanr his7-366 ade6This study
    NJ168h+ vma2::kanr his7-366 ade6-M210This study
    NJ490h− kanr-p3nmt1-3HA-skp1+ his7-366 ade615
    NJ838h+ rav1-1:13myc:kanr his7-366 ade6-M210This study
    NJ844h+ rav2::natr his7-366 ade6-M210This study
    NJ864h− kanr-p3nmt1-3HA-skp1+ his7-366 ade6rav1-13myc:kanrThis study
    NJ865h+ rav2-13myc his7-366 ade6-M210This study
    NJ883h− vma1::ura416
    NJ885h− vma3::ura4 ura4-D18
    NJ887h? vma1::ura4 rav1::kanr his7-366 ade6This study
    NJ1029h? rav2-13myc his7-366 ade6-M210 rav1::kanrThis study
    • ↵a All S. pombe strains are leu1-32 ura4-D18, except NJ885 and NJ887, which have the ura4-C190T allele instead of ura4-D18.

PreviousNext
Back to top
Download PDF
Citation Tools
Loss of Regulators of Vacuolar ATPase Function and Ceramide Synthesis Results in Multidrug Sensitivity in Schizosaccharomyces pombe
Keren Dawson, W. Mark Toone, Nic Jones, Caroline R. M. Wilkinson
Eukaryotic Cell Jun 2008, 7 (6) 926-937; DOI: 10.1128/EC.00037-08

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Email

Thank you for sharing this Eukaryotic Cell article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Loss of Regulators of Vacuolar ATPase Function and Ceramide Synthesis Results in Multidrug Sensitivity in Schizosaccharomyces pombe
(Your Name) has forwarded a page to you from Eukaryotic Cell
(Your Name) thought you would be interested in this article in Eukaryotic Cell.
Share
Loss of Regulators of Vacuolar ATPase Function and Ceramide Synthesis Results in Multidrug Sensitivity in Schizosaccharomyces pombe
Keren Dawson, W. Mark Toone, Nic Jones, Caroline R. M. Wilkinson
Eukaryotic Cell Jun 2008, 7 (6) 926-937; DOI: 10.1128/EC.00037-08
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About EC
  • For the Media
  • For Librarians
  • For Advertisers
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • Submit a Manuscript to mSphere

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

Copyright © 2019 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 1535-9778; Online ISSN: 1535-9786